BrightGene News and Activities
Presence
BrightGene develops and manufactures pharmaceutical ingredients and medicines. Its main products and services include active ingredients, generic drugs, and contract development and manufacturing for pharmaceutical companies and healthcare customers.
BrightGene products and services overview:
- Active ingredients
- Generic medicines
- Drug intermediates
- Peptide therapeutics
- CDMO services
Revenue: ~$350 million
Employees: 3,000
Headquarters: Suzhou, China
BrightGene is one of the...
BrightGene is a company listed under the stock ticker 688166 (CN).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at BrightGene
- Jiandong Yuan, Chairman of the Board, General Manager
- Tong Tong, Director
- Dongdong Xu, Independent Director
Create your alert
to follow the executive moves at BrightGene.
Biotechnology
BrightGene has 2,414 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Nura Bio has just announced a $74 Million fundraising (posted on June 22 2026).
- Memento Medicines has just announced a $93 Million fundraising (posted on June 22 2026).
- Alvotech has just announced a $165 Million fundraising (posted on June 19 2026).
Popular contacts in Biotechnology
News
Press releases by BrightGene
Social media about BrightGene
- BrightGene on Wikipedia, Google News & Yahoo Finance
- BrightGene on LinkedIn, X (Twitter) & YouTube
